Baird Current Deferred Revenue from 2010 to 2026
| BDMD Stock | 1.29 0.03 2.27% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 910.9 K | Current Value 590.9 K | Quarterly Volatility 353.2 K |
Check Baird Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Baird Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 696.4 K or Selling General Administrative of 5.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0613 or PTB Ratio of 3.97. Baird financial statements analysis is a perfect complement when working with Baird Medical Valuation or Volatility modules.
Baird | Current Deferred Revenue | Build AI portfolio with Baird Stock |
Latest Baird Medical's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Baird Medical Investment over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Baird Medical's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Baird Medical's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Baird Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 246,347 | |
| Geometric Mean | 114.74 | |
| Coefficient Of Variation | 143.39 | |
| Mean Deviation | 318,801 | |
| Median | 1.00 | |
| Standard Deviation | 353,229 | |
| Sample Variance | 124.8B | |
| Range | 910.9K | |
| R-Value | 0.81 | |
| Mean Square Error | 44.9B | |
| R-Squared | 0.66 | |
| Significance | 0.00007 | |
| Slope | 56,938 | |
| Total Sum of Squares | 2T |
Baird Current Deferred Revenue History
About Baird Medical Financial Statements
Baird Medical stakeholders use historical fundamental indicators, such as Baird Medical's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Baird Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Baird Medical's assets and liabilities are reflected in the revenues and expenses on Baird Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Baird Medical Investment. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 910.9 K | 590.9 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Baird Medical Investment is a strong investment it is important to analyze Baird Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Baird Medical's future performance. For an informed investment choice regarding Baird Stock, refer to the following important reports:Check out the analysis of Baird Medical Correlation against competitors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baird Medical. If investors know Baird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baird Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0) | Earnings Share (0.11) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
The market value of Baird Medical Investment is measured differently than its book value, which is the value of Baird that is recorded on the company's balance sheet. Investors also form their own opinion of Baird Medical's value that differs from its market value or its book value, called intrinsic value, which is Baird Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baird Medical's market value can be influenced by many factors that don't directly affect Baird Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baird Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baird Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.